BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2103360)

  • 21. [Binding of natural IgM autoantibodies DJ to T-lymphocytes and T-cell hybridomas and its possible role in apoptosis].
    Zivancević-Simonović S; Inić-Kanada A; Kosec D; Dimitrijević L
    Med Pregl; 2003; 56 Suppl 1():65-71. PubMed ID: 15510917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
    Dillman SL; Aldenderfer P; Strelkauskas A
    Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of anti-polynucleotide monoclonal antibodies from human-human hybridomas.
    Hashizume S; Murakami H; Kamei M; Hirose S; Shirai T; Yamada K; Omura H
    In Vitro Cell Dev Biol; 1987 Jan; 23(1):53-6. PubMed ID: 3804938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The production of human hybridomas from patients with malignant melanoma. The effect of pre-stimulation of lymphocytes with pokeweed mitogen.
    Warenius HM; Taylor JW; Durack BE; Cross PA
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):347-55. PubMed ID: 6345172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro immunization of human lymphocytes with human lung cancer cell line A549.
    Kawahara H; Shirahata S; Tachibana H; Murakami H
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):8-13. PubMed ID: 1576323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of autoantibodies by human-human hybridomas.
    Shoenfeld Y; Hsu-Lin SC; Gabriels JE; Silberstein LE; Furie BC; Furie B; Stollar BD; Schwartz RS
    J Clin Invest; 1982 Jul; 70(1):205-8. PubMed ID: 7085884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of PHA in producing human monoclonal thyroid autoantibodies of different subclasses.
    McLachlan SM; Fukuma N; Sarsero D; Phillips DI; Petersen VB; Pegg CA; Baylis P; Smith BR
    Hum Antibodies Hybridomas; 1990; 1(3):166-70. PubMed ID: 2103361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRL/Mp-lpr/lpr mouse derived monoclonal antibodies that recognise determinants shared by poly (ADP-ribose), single stranded DNA and left handed Z-DNA.
    Kanai Y; Akatsuka T; Kubota T; Goto S; Stollar BD
    Clin Exp Immunol; 1985 Jan; 59(1):139-45. PubMed ID: 2578906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
    Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
    Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernatants of lymphocyte cultures and human hybridomas.
    Hiepe F; Kiessig ST; Jahn S; Volk HD; Grunow R; Apostoloff E; von Baehr R
    Biomed Biochim Acta; 1986; 45(7):K29-35. PubMed ID: 3539108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
    Kjeldsen TB; Rasmussen BB; Rose C; Zeuthen J
    Cancer Res; 1988 Jun; 48(11):3208-14. PubMed ID: 3365703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.
    Smith G; Morrison CA; Maddison PJ
    Clin Exp Immunol; 1987 Jun; 68(3):552-61. PubMed ID: 2958189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation.
    Masuho Y; Sugano T; Matsumoto Y; Sawada S; Tomibe K
    Biochem Biophys Res Commun; 1986 Mar; 135(2):495-500. PubMed ID: 3008724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.
    Ichikawa K; Shimada K; Nawata Y; Ishii T; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1988 Oct; 74(1):110-4. PubMed ID: 3146452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
    Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
    Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.